tm
Seeing Is Believing
tm
Seeing Is Believing
MXCT is currently covered by 2 analysts with an average price target of $7.09. This is a potential upside of $5.93 (511.21%) from yesterday's end of day stock price of $1.16.
MaxCyte's activity chart (see below) currently has 21 price targets and 21 ratings on display. The stock rating distribution of MXCT is 75% BUY and 25% HOLD.
Highest price target for MXCT is $9, Lowest price target is $9, average price target is $9.
Most recent stock forecast was given by MARK MASSARO from BTIG on 11-Aug-2025. First documented stock forecast 24-Aug-2021.
Currently out of the existing stock ratings of MXCT, 3 are a BUY (75%), 1 are a HOLD (25%).
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
Since 11-Aug-2025
$5
5 months 13 days ago
(11-Aug-2025)
0/8 (0%)
$2.57 (105.76%)
Buy
Since 24-Aug-2021
$9
$7.84 (675.86%)
$11
10 months 12 days ago
(12-Mar-2025)
0/3 (0%)
$5.82 (183.02%)
Buy
$12
$7.98 (198.51%)
$12
2 years 3 months 18 days ago
(05-Oct-2023)
0/4 (0%)
$9.4 (361.54%)
What is MXCT (MaxCyte) average time for price targets to be met?
Which analyst has the current highest performing score on MXCT (MaxCyte) with a proven track record?
Which analyst has the current lower performing score on MXCT (MaxCyte) with a proven track record?
Which analyst has the most public recommendations on MXCT (MaxCyte)?
Which analyst is the currently most bullish on MXCT (MaxCyte)?
Which analyst is the currently most reserved on MXCT (MaxCyte)?
